NRX Pharmaceuticals, Inc. — DEF 14A Filings
13 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by NRX Pharmaceuticals, Inc. (NRXPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NRX Pharmaceuticals, Inc. has filed 13 DEF 14A documents with the SEC since 2017. To view all SEC filings by NRX Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | FORM DEF 14A | 0001437749-26-005119 | Feb 23, 2026 | Mar 23, 2026 |
| DEF 14A | FORM DEF 14A | 0001437749-24-028549 | Sep 5, 2024 | Oct 8, 2024 |
| DEF 14A | DEF 14A | 0001104659-24-033080 | Mar 11, 2024 | Mar 21, 2024 |
| DEF 14A | DEF 14A | 0001104659-23-120785 | Nov 22, 2023 | Dec 19, 2023 |
| DEF 14A | DEF 14A | 0001104659-23-002816 | Jan 10, 2023 | Feb 2, 2023 |
| DEF 14A | DEF 14A | 0001104659-22-072523 | Jun 21, 2022 | Jul 18, 2022 |
| DEF 14A | DEF 14A | 0001654954-21-003781 | Apr 1, 2021 | Apr 21, 2021 |
| DEF 14A | DEFINITIVE PROXY | 0001654954-20-013249 | Dec 7, 2020 | Dec 18, 2020 |
| DEF 14A | DEF 14A | 0001654954-20-007509 | Jul 10, 2020 | Jul 23, 2020 |
| DEF 14A | DEF 14A | 0001654954-20-002384 | Mar 9, 2020 | Mar 23, 2020 |
| DEF 14A | PROXY STATEMENT | 0001654954-19-012513 | Nov 8, 2019 | Nov 21, 2019 |
| DEF 14A | DEF 14A | 0001654954-19-009113 | Aug 9, 2019 | Aug 21, 2019 |
| DEF 14A | DEF 14A | 0001654954-19-005364 | May 7, 2019 | May 21, 2019 |